4WAF | Crystal Structure of a novel tetrahydropyrazolo[1,5-a]pyrazine in an engineered PI3K alpha | date | |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Knapp, M.S., Elling, R.A. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.39 | ||||||||||||
ligand | 3K6 | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Structure-Based Drug Design of Novel Potent and Selective Tetrahydropyrazolo[1,5-a]pyrazines as ATR Inhibitors., Barsanti PA, Aversa RJ, Jin X, Pan Y, Lu Y, Elling R, Jain R, Knapp M, Lan J, Lin X, Rudewicz P, Sim J, Taricani L, Thomas G, Xiao L, Yue Q, ACS Med Chem Lett. 2014 Nov 20;6(1):37-41. doi: 10.1021/ml500353p. eCollection, 2015 Jan 8. PMID:25589927 |
Data retrieval |
View 4WAF in 3D |
Visual 3D analysis of 4WAF |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4WAF |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |